Boditech Med Inc. (KOSDAQ:206640)

Market Cap	287.97B
Revenue (ttm)	151.75B
Net Income (ttm)	27.23B
Shares Out	21.78M
EPS (ttm)	1,250.34
PE Ratio	10.57
Forward PE	n/a
Dividend	150.00 (1.14%)
Ex-Dividend Date	Mar 31, 2025

Volume	43,322
Average Volume	42,794
Open	13,230
Previous Close	13,220
Day's Range	13,110 - 13,330
52-Week Range	12,940 - 18,670
Beta	0.23
RSI	39.83
Earnings Date	Nov 12, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 541
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.